Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
Background For patients with MS, medication switches increase the risk of disease reactivation. Objective Compare discontinuation rates due to treatment failure or side effects between teriflunomide and dimethyl fumarate, and investigate clinical variables affecting discontinuation rates. Methods Al...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2021-06-01
|
| Col·lecció: | Multiple Sclerosis Journal - Experimental, Translational and Clinical |
| Accés en línia: | https://doi.org/10.1177/20552173211022027 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|